PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16160912-0 2005 The combined effects of zafirlukast, prednisone, and inhaled budesonide on IL-13 and IFN-gamma secretion. Budesonide 61-71 interferon gamma Homo sapiens 85-94 24717973-4 2014 Treatment of MSCs with glucocorticoids, budesonide or dexamethasone, enhanced IDO expression following IFN-gamma stimulation in multiple donors and was able to restore IDO expression in over-passaged MSCs. Budesonide 40-50 interferon gamma Homo sapiens 103-112 22766315-4 2012 Moreover, we evaluated the potential effect of treatment with budesonide and/or formoterol on IFN-gamma secretion in vitro. Budesonide 62-72 interferon gamma Homo sapiens 94-103 22766315-13 2012 Even if in vitro experiments with budesonide, alone or in combination with formoterol, showed a modulation of NKG2D receptor expression and IFN-gamma production, our ex vivo results show that real life LABA and ICS treatment does not influence peripheral NK cells count and their receptors phenotype. Budesonide 34-44 interferon gamma Homo sapiens 140-149 34414894-9 2021 The combination of theophylline and budesonide suppressed synthesis of IL-4 and CXCL8 by NK and NKT-like cells, as well as the production of TNFalpha and IFNgamma by NK cells stronger than budesonide alone. Budesonide 36-46 interferon gamma Homo sapiens 154-162 9298179-5 1997 Budesonide was added at concentrations corresponding to 10(-8), 10(-7), and 10(-6) mol/l in cultured epithelial cells, either in the absence of any stimulus or in the presence of interferon-gamma (IFN-gamma) at 500 U/ml. Budesonide 0-10 interferon gamma Homo sapiens 179-195 9298179-5 1997 Budesonide was added at concentrations corresponding to 10(-8), 10(-7), and 10(-6) mol/l in cultured epithelial cells, either in the absence of any stimulus or in the presence of interferon-gamma (IFN-gamma) at 500 U/ml. Budesonide 0-10 interferon gamma Homo sapiens 197-206 9298179-9 1997 In addition, budesonide reduced surface ICAM-1 upregulation induced by IFN-gamma at 500 U/ml (P < 0.05). Budesonide 13-23 interferon gamma Homo sapiens 71-80 8613948-6 1996 Budesonide (10(-7) M) dramatically reduced A-PBM proliferation (measured by 3H-thymidine incorporation) and cytokine (IL-1beta, IL-2, IL-6, IFN-gamma, TNF-alpha) production, but was not cytotoxic to immune cells. Budesonide 0-10 interferon gamma Homo sapiens 140-149 7541423-6 1995 Pretreatment of cells with the glucocorticoid budesonide (10(-10)-10(-7) M) for 24 h inhibited expression of RANTES mRNA and protein stimulated by either TNF-alpha or TNF-alpha plus IFN-gamma in a concentration- and time-dependent manner. Budesonide 46-56 interferon gamma Homo sapiens 182-191 34414894-6 2021 Budesonide reduced synthesis of interleukin 4 (IL-4), CXCL8, tumor necrosis factor alpha (TNFalpha) by NK and NKT-like cells, as well as production of interferon gamma (IFNgamma) by NK cells. Budesonide 0-10 interferon gamma Homo sapiens 151-167 34414894-6 2021 Budesonide reduced synthesis of interleukin 4 (IL-4), CXCL8, tumor necrosis factor alpha (TNFalpha) by NK and NKT-like cells, as well as production of interferon gamma (IFNgamma) by NK cells. Budesonide 0-10 interferon gamma Homo sapiens 169-177 10988100-7 2000 Budesonide decreased ex vivo generation of IL-5 and IFN-gamma by BAL cells. Budesonide 0-10 interferon gamma Homo sapiens 52-61 34414894-9 2021 The combination of theophylline and budesonide suppressed synthesis of IL-4 and CXCL8 by NK and NKT-like cells, as well as the production of TNFalpha and IFNgamma by NK cells stronger than budesonide alone. Budesonide 189-199 interferon gamma Homo sapiens 154-162 35538539-8 2022 RESULTS: Our results show that both tanimilast and budesonide reduced the production of the immunostimulatory cytokine IFN-gamma by CD4+ T cells. Budesonide 51-61 interferon gamma Homo sapiens 119-128